IP Verse

Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia

Patent No. EP3638243 (titled "Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia") was filed by Celgene on Jun 13, 2018. The application was issued on Aug 7, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDMay 7, 2025MAIWALD
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 5, 2025WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3638243

CELGENE
Application Number
EP18816685A
Filing Date
Jun 13, 2018
Status
Granted And Under Opposition
Jul 5, 2024
Publication Date
Aug 7, 2024
External Links
Slate, Register , Google Patents